Skip to content
urapidil

Structure via PubChem · Public domain (PubChem)

EntityQ418922· pop 15· linked from 1,830 articles

Urapidil is a sympatholytic antihypertensive drug. It acts as an α1-adrenoceptor antagonist and as an 5-HT1A receptor agonist. Although an initial report suggested that urapidil was also an α2-adrenoceptor agonist, this was not substantiated in later studies that demonstrated it was devoid of agonist actions in the dog saphenous vein and the guinea-pig ileum. Unlike some other α1-adrenoceptor antagonists, urapidil does not elicit reflex tachycardia, and this may be related to its weak β1-adrenoceptor antagonist activity, as well as its effect on cardiac vagal drive. Urapidil is currently not a

Chemical data

Formula
C20H29N5O3
Molecular weight
387.5 g/mol
IUPAC name
6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione
SMILES
CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC
InChIKey
ICMGLRUYEQNHPF-UHFFFAOYSA-N
XLogP
1.5
Polar surface area
68.4 Ų
H-bond donors
1
H-bond acceptors
6
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 3
Molecule type
Small molecule
Indications
hypertension, preeclampsia, stroke, cerebrovascular disorder

via ChEMBL · EBI

Wikidata facts

Mass
387.227
Has use
medication
Show 6 more facts
chemical formula
C₂₀H₂₉N₅O₃
canonical SMILES
CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC
route of administration
oral administration
subject has role
alpha blocker
Commons category
Urapidil
defined daily dose
50
Sources (4)

via Wikidata · CC0

~3 min read

Encyclopedic overview

4 sections
Contents
  • Medical uses
  • D/T and reperfusion injuries
  • See also
  • References

{{Drugbox | IUPAC_name = 6-({3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl}amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione | image = Urapidil structure.svg | image_class = skin-invert-image | width = 250px

| tradename = | Drugs.com = | pregnancy_category = | legal_status = Rx-only | routes_of_administration = Oral

Excerpted from Wikipedia’s “urapidil” article, available under the CC BY-SA 4.0 licence.

Gallery (2)